Evaluating appropriateness of treatment for Crohn's disease: Feasibility of an explicit approach

Digestion

Volumn 75, Issue 1, 2007, Pages 46-52

  Guessous, Idris ^a   Juillerat, Pascal ^b   Pittet, Valerie ^a   Froehlich, Florian ^b,c   Burnand, Bernard ^a   Mottet, Christian ^b   Felley, Christian ^b   Michetti, Pierre ^b   Vader, John Paul ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Appropriateness method; Appropriateness of care; Crohn's disease; European Panel on the Appropriateness of Crohn's Disease Therapy; RAND

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; PREDNISONE; SALAZOSULFAPYRIDINE;

ARTICLE; COHORT ANALYSIS; CROHN DISEASE; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; HUMAN; MEDICAL RECORD; PATIENT CARE; PILOT STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT RESPONSE;

CROHN DISEASE; HUMANS; QUALITY ASSURANCE, HEALTH CARE;

EID: 34248137075     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101566     Document Type: Article

References (23)

1. Tremaine WJ, Sandborn WJ, Loftus EV, Kenan ML, Petterson TM, Zinsmeister AR, Silverstein MD: A prospective cohort study of practice guidelines in inflammatory bowel disease. Am J Gastroenterol 2001;96:2401-2406.
2. Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA: Are patients with inflammatory bowel disease receiving optimal care? Am J Gastroenterol 2005;100:1357-1361.
3. Sachar DB: Ten common errors in the management of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:205-209.
4. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, van het Loo M, McDonnell J, Vader JP, Kahan JP: The RAND/ UCLA Appropriateness Method User's Manual. Santa Monica, RAND, MR-1269/RE/DGXII, 2001.
5. Vader JP, Froehlich F, Juillerat P, Burnand B, Felley C, Gonvers JJ, Mottet C, Pittet V, Dubois RW, Wietlisbach V, Michetti P: Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach - EPACT. Digestion 2006;73:237-248.
6. Michetti P, Juillerat P, Mottet C, Gonvers JJ, Burnand B, Vader JP, Froehlich F, Felley C: Therapy of mild to moderate luminal Crohn's disease. Digestion 2005;71:13-18.
7. Michetti P, Mottet C, Juillerat P, Felley C, Vader JP, Burnand B, Gonvers JJ, Froehlich F: Severe and steroid-resistant Crohn's disease. Digestion 2005;71:19-25.
8. Felley C, Mottet C, Juillerat P, Froehlich F, Burnand B, Vader JP, Michetti P, Gonvers JJ: Fistulizing Crohn's disease. Digestion 2005;71:26-28.
9. Froehlich F, Juillerat P, Mottet C, Felley C, Vader JP, Burnand B, Gonvers JJ, Michetti P: Obstructive fibrostenotic Crohn's disease. Digestion 2005;71:29-30.
10. Juillerat P, Mottet C, Froehlich F, Felley C, Vader JP, Burnand B, Gonvers JJ, Michetti P: Extraintestinal manifestations of Crohn's disease. Digestion 2005;71:31-36.
11. Mottet C, Juillerat P, Gonvers JJ, Michetti P, Burnand B, Vader JP, Felley C, Froehlich F: Treatment of gastroduodenal Crohn's disease. Digestion 2005;71:37-40.
12. Gonvers JJ, Juillerat P, Mottet C, Felley C, Burnand B, Vader JP, Michetti P, Froehlich F: Maintenance of remission in Crohn's disease. Digestion 2005;71:41-48.
13. European Panel on the Appropriateness of Crohn's Disease Therapy: Available at www.epact.ch.
14. Steinhart AH, Hemphill D, Greenberg GR: Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Am J Gastroenterol 1994;89:2116-2124.
15. Camma C, Giunta M, Rosselli M, Cottone M: Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997;113:1465-1473.
16. Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, D'Haens G, Kitis G, Cortot A, Prantera C, Marteau P, Colombel JF, Gionchetti P, Bouhnik Y, Tiret E, Kroesen J, Starlinger M, Mortensen NJ: European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut 2006;55(suppl 1):i16-i35.
17. Akobeng AK, Gardener E: Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's Disease. Cochrane Database Syst Rev 2005;1:CD003715.
18. Jeannot JG, Vader JP, Porchet F, Larequi-Lauber T, Burnand B: Can the decision to operate be judged retrospectively? A study of medical records. Eur J Surg 1999;165:516-521.
19. Audet AM, Goodnough LT, Parvin CA: Evaluating the appropriateness of red blood cell transfusions: the limitations of retrospective medical record reviews. Int J Qual Health Care 1996;8:41-49.
20. Bernstein SJ, Hilborne LH, Leape LL, Fiske ME, Park RE, Kamberg CJ, Brook RH: The appropriateness of use of coronary angiography in New York State. JAMA 1993;269:766-769.
21. Leape LL, Hilborne LH, Park RE, Bernstein SJ, Kamberg CJ, Sherwood M, Brook RH: The appropriateness of use of coronary artery bypass graft surgery in New York State. JAMA 1993;269:753-760.
22. Winslow CM, Solomon DH, Chassin MR, Kosecoff J, Merrick NJ, Brook RH: The appropriateness of carotid endarterectomy. N Engl J Med 1988;318:721-727.
23. Bernstein SJ, McGlynn EA, Siu AL, Roth CP, Sherwood MJ, Keesey JW, Kosecoff J, Hicks NR, Brook RH: The appropriateness of hysterectomy: a comparison of care in seven health plans. Health Maintenance Organization Quality of Care Consortium. JAMA 1993;269:2398-2402.